IRLAB Therapeutics AB Class A's total assets for Q3 2025 were kr170.55M, a decrease of ― from the previous quarter. SE:IRLAB.A total liabilities were kr116.34M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.